Tuesday, April 23, 2013

Data from Phase 3 Studies of Gilead’s Sofosbuvir for Hepatitis C To Be Presented at 48th Annual EASL Meeting; Findings Published Online Today in The New England Journal of Medicine | Gilead

Data from Phase 3 Studies of Gilead’s Sofosbuvir for Hepatitis C To Be Presented at 48th Annual EASL Meeting; Findings Published Online Today in <i>The New England Journal of Medicine</i> | Gilead
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.